ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $149,000 | -57.5% | 25,865 | 0.0% | 0.01% | -45.0% |
| Q3 2018 | $351,000 | +14.3% | 25,865 | 0.0% | 0.02% | +5.3% |
| Q2 2018 | $307,000 | +5.5% | 25,865 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $291,000 | -64.5% | 25,865 | -78.9% | 0.02% | -63.5% |
| Q4 2017 | $819,000 | -18.4% | 122,644 | 0.0% | 0.05% | -16.1% |
| Q3 2017 | $1,004,000 | +19.8% | 122,644 | -34.3% | 0.06% | +10.7% |
| Q2 2017 | $838,000 | -22.3% | 186,578 | -4.6% | 0.06% | -24.3% |
| Q1 2017 | $1,078,000 | – | 195,571 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |